Business EconomyPosted at: May 14 2025 6:08PM


Growing prominence of Life science industry impacts Real Estate development growth globally : CBRE Report

Hyderabad, May 14 (UNI) The growing prominence of the life sciences industry has significantly impacted the growth of real estate development globally, with more than 35 million sq. ft. of lab/research and development (R&D) properties under construction last year, said CBRE, world’s leading real estate consulting firm, in its report ‘Global Life Sciences Atlas,’ released on Wednesday.
While U.S. markets top the world’s largest life sciences R&D centres, other mainstays can be found in Asia-Pacific (Hyderabad, Beijing, Shanghai, Greater Tokyo), Canada (Toronto, Montreal) and Europe (Cambridge, U.K., Paris), the report revealed.
As per the report, innovation, evolving healthcare needs, and demographic shifts are driving increased demand across the pharmaceutical, biotech, and med-tech industries, the report stated.
Globally, leading hubs such as Boston-Cambridge, the San Francisco Bay Area, Beijing, Shanghai, and Cambridge (UK) are shaping the next wave of life sciences growth.
In the Asia-Pacific region, Beijing, Shanghai, Singapore, and Greater Tokyo have emerged as the largest markets for life sciences labs and R&D space, it said.
As per the findings, Hyderabad emerged as a prominent global centre of life sciences manufacturing activity in India.
In the APAC region life sciences landscape, India has a leading position, driven by the expansion of pharmaceutical, biotech and medical devices companies.
The report pointed out that Hyderabad is the key contributor and largest life sciences manufacturing and R&D cluster, undertaking research, training, and manufacturing.
The Hyderabad city accounts for nearly one-third of the country’s pharmaceutical production, one-fifth of its pharmaceutical exports, and one-third of global vaccine output.
Gross office leasing space by life sciences firms in India increased by 56 percent
Y-o-Y to about 5.8 million sq. ft., witnessing the highest-ever leasing activity by the sector, it said.
This growth has been driven by several factors, including increased foreign direct investment (FDI), enhanced manufacturing capabilities, a cost-effective talent pool, greater emphasis on R&D, and demographic trends such as a rising population and increasing life expectancy.
Hyderabad’s Genome Valley is home to over 200 biotech and pharmaceutical companies from 18 countries. Six of the world’s top 10 research and development (R&D) companies have facilities in Genome Valley.
More than 20 life sciences and medical technology incubators are in Hyderabad, the highest concentration in India.
The ecosystem supports diverse operations ranging from drug discovery to clinical research and large-scale manufacturing. Leading players include Aurigene Pharma Services, Bharat Biotech, Biological E, Chemo, Cohance, Ferring, Indian Immunologicals, Novartis, Sai Life Sciences and Syngene.
This momentum is being further reinforced by the Government of Telangana through progressive governance and strategic public-private partnerships.
The recently launched Life Sciences Policy 2023–2028 offers a range of fiscal incentives and ready-to-use infrastructure to attract investment. Mega projects such as Hyderabad Pharma City—envisioned as the world’s largest integrated pharma cluster—and the Medical Devices Park are further cementing the city’s leadership as a comprehensive, end-to-end life sciences powerhouse.
Anshuman Magazine, Chairman & CEO - India, South-East Asia, Middle East & Africa, CBRE, said, “Hyderabad’s rise as a global life sciences manufacturing hub reflects the growing maturity and competitiveness of India’s life sciences sector. The city’s robust infrastructure, progressive policies, and exceptional scientific talent have made it a preferred destination for global pharmaceutical and biotech firms. Genome Valley is a shining example of how strategic planning and public-private collaboration can create a thriving ecosystem for innovation and scale. As India’s life sciences industry gains unprecedented momentum, Hyderabad is at the heart of this transformation-its integrated clusters and visionary frameworks positioning Genome Valley among the world’s most dynamic life sciences hubs and signalling India’s readiness to lead the next phase of global life sciences growth.”
Ada Choi, Head of Research -APAC, CBRE, said, “The increasing prominence of the life sciences industry is driving substantial real estate development on a global scale. The Asia-Pacific region is at the forefront of this trend, leading global life sciences construction activity. Notably, China currently exhibits the highest volume of ongoing laboratory construction worldwide, while India is establishing itself as a compelling hub for life sciences manufacturing. This underscores the robust growth trajectory of the life sciences sector in the region and suggests that strengthening demand dynamics will likely fuel further expansion in the coming years.”
Looking ahead, India’s life sciences sector is on a clear trajectory of accelerated growth, powered by a convergence of strategic policy frameworks, rising global demand, and innovation-led development, said Ada Chol.
Hyderabad’s continued expansion of integrated life sciences infrastructure, coupled with India’s growing presence in the global supply chain, positions the country to play a defining role in shaping the next decade of healthcare and biotech innovation. As new clusters emerge and existing ecosystems mature, India is set to become a global benchmark for end-to-end life sciences excellence, from research to large-scale manufacturing, Ada Chol added.
UNI KNR BD
Please log in to get detailed story.
Tags: #Growing prominence of Life science industry impacts Real Estate development growth globally : CBRE Report
More News
India's engineering goods export sector continues to show resilience: EEPC India

India's engineering goods export sector continues to show resilience: EEPC India

17 Jun 2025 | 11:51 AM

Kolkata, June 17 (UNI) India's engineering goods export sector continues to show resilience despite persistent global challenges, though it recorded a marginal dip in shipments during May 2025, the cumulative number stays positive, according to EEPC India.

see more..
Rupee up by 10 paise against USD

Rupee up by 10 paise against USD

17 Jun 2025 | 10:28 AM

Mumbai, June 17 (UNI) The Rupee on Tuesday appreciated by 10 paise at 85.96 in the opening session on weak dollar demand by bankers and importers and the easing of crude oil prices, forex traders said.

see more..
Sensex falls by 163 63 points

Sensex falls by 163 63 points

17 Jun 2025 | 10:22 AM

Mumbai, June 17 (UNI) The BSE Sensex on Tuesday fell by 163.63 point to 81,632.52 in early trade tracking negative cues from Global peers.

see more..

Bata Group appoints new Chief Executive Officer

17 Jun 2025 | 12:40 AM

Kolkata, June 16 (UNI) The Bata Group today announced the appointment of Panos Mytaros as its new Global Chief Executive Officer, effective 15th September 2025, succeeding Sandeep Kataria, who has led the Group since 2020.

see more..
Sensex Jumps 677 55 points

Sensex Jumps 677 55 points

16 Jun 2025 | 7:34 PM

Mumbai, Jun 16 (UNI) BSE Sensex on Monday rebounded by 677.55 to close at 81,796.15, after two straight sessions of losses, despite lingering concerns over rising geopolitical tensions between Israel and Iran that continued to impact the global market sentiment.

see more..